Evidence map›Paper›PMID 34485508›Full record

ArticleBioMed research international2021

Inhibiting PP2Ac

Zhaoxiang Cheng, Shan Gao, Xiaojie Liang, Chao Lian, Jianquan Chen, Chao Fang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. The mFrontiers in cell and developmental biology · 2026
    Review
  2. Review
  3. NJournal of translational internal medicine · 2024
    Article
  4. Review
  5. New insights into the regulation of METTL3 and its role in tumors.Cell communication and signaling : CCS · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhaoxiang ChengDepartment of General Surgery, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.ORCID https://orcid.org/0000-0003-3474-2689
Shan GaoDepartment of General Surgery, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.
Xiaojie LiangDepartment of General Surgery, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.
Chao LianDepartment of Central Laboratory, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.ORCID https://orcid.org/0000-0003-2991-8571
Jianquan ChenDepartment of Central Laboratory, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.ORCID https://orcid.org/0000-0003-3406-0733
Chao FangDepartment of General Surgery, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.ORCID https://orcid.org/0000-0002-9537-8262
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is aimed at exploring the relationship between the phosphatase 2A catalytic subunit C

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsCell Line, TumorCell ProliferationComputational BiologyDisease ProgressionHeterograftsHumansMaleMethyltransferasesMiceMice, Inbred BALB CMice, NudePhosphorylationProtein Phosphatase 2Stomach NeoplasmsAtaxia Telangiectasia Mutated ProteinsATM protein, humanMethyltransferasesMETTL3 protein, humanPPP2CA protein, humanProtein Phosphatase 2

Identifiers

PMID34485508
PMCPMC8410407
OpenAlexW3194249527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.